The current financial score of Mesa Laboratories Inc is 8.51. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 60.14M, representing a year-over-year increase of 1.00%, while its net profit experienced a year-over-year increase of 40.32%.
The current valuation score of Mesa Laboratories Inc is 8.98. Its current P/E ratio is 200.65, which is 425.67% below the recent high of 1054.75 and 537.64% above the recent low of -878.12.
The current earnings forecast score of Mesa Laboratories Inc is 7.33. The average price target is 117.50, with a high of 125.00 and a low of 110.00.
The current price momentum score of Mesa Laboratories Inc is 3.43. Currently, the stock price is trading between the resistance level at 136.69 and the support level at 123.06, making it suitable for range-bound swing trading.
The current institutional shareholding score of Mesa Laboratories Inc is 10.00. The latest institutional shareholding proportion is 100.49%, representing a quarter-over-quarter increase of 17.49%. The largest institutional shareholder is Diamond Hill Capital, holding a total of 155.77K shares, representing 0.12% of shares outstanding, with 674.81% increase in holdings.
The current risk assessment score of Mesa Laboratories Inc is 6.24. The company's beta value is 0.94. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.